US Stock MarketDetailed Quotes

IRD Opus Genetics

Watchlist
  • 0.9544
  • +0.0164+1.75%
Close May 2 16:00 ET
  • 0.9649
  • +0.0105+1.10%
Post 19:47 ET
45.03MMarket Cap-0.44P/E (TTM)

About Opus Genetics Company

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Company Profile

SymbolIRD
Company NameOpus Genetics
Founded2018
CEODr. George Magrath, PhD
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address8 Davis Drive,Suite 220
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-248-957-9024

Company Executives

  • Name
  • Position
  • Salary
  • Dr. George Magrath, PhD
  • Director and Chief Executive Officer
  • 2.67M
  • Nirav Jhaveri, C.F.A.,M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Joseph K. Schachle
  • Chief Operating Officer
  • --
  • Dr. Ashwath Jayagopal, PhD
  • Chief Scientific and Development Officer
  • --
  • Amy Rabourn
  • Senior Vice President, Finance
  • 789.92K
  • Bernhard Hoffmann
  • Senior Vice President, Corporate Development
  • 789.92K
  • Cam S. Gallagher
  • Chairman of the Board
  • 174.62K
  • Dr. Benjamin R. Yerxa,PhD
  • Director and President
  • --
  • Dr. Jean Bennett, M.D.,Pd.D
  • Director
  • --
  • Susan K. Benton
  • Independent Director
  • 135.34K
  • Sean Ainsworth
  • Lead Independent Director
  • 149.56K
  • Richard J. Rodgers
  • Independent Director
  • 899.08K
  • Dr. James S.J. Manuso, M.B.A.,PhD
  • Independent Director
  • 154.81K
  • Dr. Adrienne L. Graves,PhD
  • Independent Director
  • --

Market Insights

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More